Clinical trial / 2005
Hydrolyzed formula reduced specific diabetes-associated autoantibodies in infants with genetic risk.
A randomized pilot trial assigned 242 newborn infants with HLA susceptibility and a first-degree relative with type 1 diabetes to receive casein hydrolysate or conventional cow's milk formula until 6 to 8 months of age. Over a mean 4.7-year follow-up, cumulative autoantibody emergence was somewhat lower with hydrolysed formula. Adjusted life-table analysis indicated significant protection against islet cell antibodies (P = 0.02) and at least one autoantibody (P = 0.03).
- Study type
- Randomized controlled trial
- Who was studied
- 242 newborn infants with type 1 diabetes risk alleles and affected relatives
- What was measured
- Emergence of diabetes-associated autoantibodies
THE PAPER
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study.
Akerblom HK, Virtanen SM, Ilonen J, Savilahti E, Vaarala O, Reunanen A, Teramo K, Hämäläinen AM, Paronen J, Riikjärv MA, Ormisson A, Ludvigsson J, Dosch HM, Hakulinen T, Knip M, National TRIGR Study Groups. Diabetologia, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.